Related Experiment Videos
Community-Based Personalised Lifestyle Intervention Guided by Intermittent Continuous Glucose Monitoring in Adults
Yaqing Liu1, Shan Zheng1, Zifu Yu2
1School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Diabetes, Obesity & Metabolism
|August 13, 2026
Summary
A lifestyle intervention using continuous glucose monitoring (CGM) did not significantly improve type 2 diabetes management. Further research is needed to determine if sustained engagement can enhance effectiveness for better glycaemic control.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Public Health
Background:
- Type 2 diabetes management often relies on standard care.
- Personalized lifestyle interventions show promise but require optimization.
- Continuous glucose monitoring (CGM) offers real-time data for diabetes management.
Purpose of the Study:
- To assess if a community-based lifestyle intervention guided by intermittent continuous glucose monitoring (CGM) improves glycaemic and cardiometabolic outcomes in adults with type 2 diabetes.
- To compare CGM-guided intervention against usual community diabetes care.
Main Methods:
- A multicentre, open-label randomized trial involving 180 adults with type 2 diabetes (HbA1c >7.0%).
- Participants were assigned to either a CGM-guided intervention or usual care for 12 months.
- The intervention included intermittent CGM use with personalized lifestyle guidance and supervised exercise.
Main Results:
- The primary outcome, HbA1c at 3 months, showed no significant difference between the intervention and control groups (adjusted difference -0.09 percentage points, p=0.573).
- No significant improvements in HbA1c or secondary cardiometabolic outcomes were observed at 6 or 12 months.
- Exploratory analyses did not identify any subgroups that benefited more from the intervention.
Conclusions:
- The community-based, intermittently CGM-guided lifestyle intervention did not significantly improve glycaemic or cardiometabolic outcomes compared to usual care.
- Further evaluation is needed to determine if sustained feedback and engagement strategies can enhance the effectiveness of such interventions before routine implementation.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...